Colon primary cancer with metastatic

Colon primary cancer with metastatic 

To Order Contact us: lieven@wlsolutions.be

Ovary primary carcinoma with matched metastatic carcinoma tissue array
OV812 each
EUR 270
Description: Ovary primary carcinoma with matched metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 40 cases/80 cores

Breast cancer with matched metastatic carcinoma or breast tissue array
BRM961a each
EUR 384
Description: Breast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores

Lung cancer with matched lymph node metastatic carcinoma tissue array
LC817b each
EUR 258
Description: Lung cancer with matched lymph node metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing LC817a

Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue
LC953 each
EUR 1434
Description: Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue, including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952

Breast cancer with matched metastatic carcinoma of lymph node tissue array
BR1005b each
EUR 306
Description: Breast cancer with matched metastatic carcinoma of lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1005a

Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue
CO952a each
EUR 1434
Description: Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue, with TNM, clinical stage and survival data, 30 cases/95 cores.

Cervix cancer and normal tissue array with CIN and metastatic carcinoma
CR208 each
EUR 546
Description: Cervix cancer and normal tissue array with CIN and metastatic carcinoma, including pathology grade, TNM and clinical stage, 69 cases/207 cores

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380553-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380553-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380553-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380553-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380553-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380892-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380892-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380892-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380892-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380892-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380894-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380894-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380894-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380894-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)
MBS4380894-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

Liver metastatic cancer tissue array
MLV801 each
EUR 354
Description: Liver metastatic cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores

Metastatic esophageal cancer tissue array
ES806 each
EUR 306
Description: Metastatic esophageal cancer tissue array, 40 cases/80 cores

Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma
KD951a each
EUR 1434
Description: Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma, with TNM, clinical stage, pathology grade and survival data, 32 cases/95 cores,replacing KD951

Multiple organ metastatic cancer tissue array
MT2081 each
EUR 474
Description: Multiple organ metastatic cancer tissue array, 19 organ/104 cases/208 cores

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 1mg/mL
BNUM3750-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 0.2mg/mL
BNUB3750-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), 0.2mg/mL
BNUB3750-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Cancer Antigen CEA Antigen (Human Metastatic Liver)
VAng-Wyb8645-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL.

Malignant melanoma and metastatic malignant melanoma TMA with 6 matched cancer adjacent tissue samples
ME551 each
EUR 270
Description: Malignant melanoma and metastatic malignant melanoma TMA with 6 matched cancer adjacent tissue samples, including TNM and clinical stage (reference AJCC th version), 49cases/55 cores (core size 1.5mm) Recent Year Collection

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 1mg/mL
BNUM2225-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 1mg/mL
BNUM2226-50 1uL
EUR 396
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 0.2mg/mL
BNUB2225-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), 0.2mg/mL
BNUB2225-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 0.2mg/mL
BNUB2226-100 1uL
EUR 225
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), 0.2mg/mL
BNUB2226-500 1uL
EUR 485
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Lung
D8235152-PM-10 2x10 ug
EUR 555.8

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Liver
D8235149-PM-10 2x10 ug
EUR 555.8

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Breast
D8235086-PM-10 2x10 ug
EUR 555.8

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Kidney
D8235142-PM-10 2x10 ug
EUR 555.8

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Rectum
D8235206-PM-10 2x10 ug
EUR 555.8

Matched Pair - DNA - Human Primary and Metastatic Tumor Tissue: Stomach
D8235248-PM-10 2x10 ug
EUR 555.8

Breast cancer and matched metastatic carcinoma tissue array
BR10010f each
EUR 354
Description: Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade,IHC (ER,PR,Her-2,Ki67) markers results, 50 cases/100 cores, replacing BR10010e

Breast cancer and matched metastatic carcinoma tissue array
BR20837a each
EUR 546
Description: Breast cancer and matched metastatic carcinoma tissue array, including TNM, clinical stage and pathology grade, 104 cases/ 208 cores, replacing BR20837

Cancer of the cervix paired with metastatic tumors in lymph nodes, 12 cases (1.5mm)HumanReproductive systemCervixMalignant
CXM481 1
EUR 289

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF488A conjugate, 0.1mg/mL
BNC883750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF488A conjugate, 0.1mg/mL
BNC883750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF594 conjugate, 0.1mg/mL
BNC943750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF594 conjugate, 0.1mg/mL
BNC943750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF568 conjugate, 0.1mg/mL
BNC683750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF568 conjugate, 0.1mg/mL
BNC683750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), Biotin conjugate, 0.1mg/mL
BNCB3750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), Biotin conjugate, 0.1mg/mL
BNCB3750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF640R conjugate, 0.1mg/mL
BNC403750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF640R conjugate, 0.1mg/mL
BNC403750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF405S conjugate, 0.1mg/mL
BNC043750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF405S conjugate, 0.1mg/mL
BNC043750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF647 conjugate, 0.1mg/mL
BNC473750-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(FABP5/3750), CF647 conjugate, 0.1mg/mL
BNC473750-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Liver
C8235149-PM 10 reactions x2
EUR 848.4

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Lung
C8235152-PM 10 reactions x2
EUR 848.4

Cancer Antigen CA 19-9 Antigen (Human metastatic liver carcinoma)
VAng-Wyb8635-inquire inquire Ask for price
Description: CA 19-9 (Gastrointestinal Cancer), Antigen Grade, Cancer antigen from Human metastatic liver carcinoma, 2900.0 kIU/mL.

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Breast
C8235086-PM 10 reactions x2
EUR 848.4

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Kidney
C8235142-PM 10 reactions x2
EUR 848.4

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Rectum
C8235206-PM 10 reactions x2
EUR 848.4

Matched Pair - cDNA - Human Primary and Matched Metastatic Tumor Tissue: Stomach
C8235248-PM 10 reactions x2
EUR 848.4

Metastatic Tumor Tissue Array - 18 cases of metastatic cancers from 4 anatomic sites
Z7020073 5 slides
EUR 1125.6
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Metastatic Tumor Tissue Array - 48 cases of metastatic cancers from 8 anatomic sites
Z7020074 5 slides
EUR 1657.2
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool.

Cancer of the colon paired with metastasis, 48 cases (1.5mm)HumanDigestive systemColonMalignant, metastasis
COM961 1
EUR 448

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF568 conjugate, 0.1mg/mL
BNC682225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF568 conjugate, 0.1mg/mL
BNC682225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF568 conjugate, 0.1mg/mL
BNC682226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF568 conjugate, 0.1mg/mL
BNC682226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF594 conjugate, 0.1mg/mL
BNC942225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF594 conjugate, 0.1mg/mL
BNC942225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL
BNC942226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF594 conjugate, 0.1mg/mL
BNC942226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF647 conjugate, 0.1mg/mL
BNC472225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF647 conjugate, 0.1mg/mL
BNC472225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF647 conjugate, 0.1mg/mL
BNC472226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF647 conjugate, 0.1mg/mL
BNC472226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208
UBD208a row: 12; column: 16; cores: 192; cases: 64
EUR 546
Description: Multiple bladder carcinoma with bladder tissue microarray, containing 38 cases of urothelial carcinoma, 6 squamous cell carcinoma, 7 adenocarcinoma, 4 metastatic urothelial carcinoma, 9 bladder tissue, triplicated cores per case

Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores
FMG1001 row: 10; column: 10; cores: 100; cases: 96
EUR 258
Description: Breast cancer and breast tissue microarray, contaning 44 cases of invasive carcinoma of no special type, 5 medullary carcinoma, 1 neuroendocrine carcinoma, 37 metastatic invasive carcinoma of no special type, 2 metastatic lobular carcinoma, 1 metastatic medullary carcinoma, 3 breast tissue, 7 adjacent normal breast tissue, single core per block

Colon adenocarcinoma and metastatic adenocarcinoma tissue array
CO953a each
EUR 1434
Description: Colon adenocarcinoma and metastatic adenocarcinoma tissue array, with matched colon tissue, including survival data, pathology grade, TNM and clinical stage, 39 cases/96 cores, replacing CO953

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF488A conjugate, 0.1mg/mL
BNC882225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF488A conjugate, 0.1mg/mL
BNC882225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF488A conjugate, 0.1mg/mL
BNC882226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF488A conjugate, 0.1mg/mL
BNC882226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), Biotin conjugate, 0.1mg/mL
BNCB2225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), Biotin conjugate, 0.1mg/mL
BNCB2225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), Biotin conjugate, 0.1mg/mL
BNCB2226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), Biotin conjugate, 0.1mg/mL
BNCB2226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF640R conjugate, 0.1mg/mL
BNC402225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF640R conjugate, 0.1mg/mL
BNC402225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF640R conjugate, 0.1mg/mL
BNC402226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF640R conjugate, 0.1mg/mL
BNC402226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF405S conjugate, 0.1mg/mL
BNC042225-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP5 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP5-3), CF405S conjugate, 0.1mg/mL
BNC042225-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF405S conjugate, 0.1mg/mL
BNC042226-100 1uL
EUR 192
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

FABP2 (Marker of Metastatic Potential in Colorectal Cancer)(CPTC-FABP2-3), CF405S conjugate, 0.1mg/mL
BNC042226-500 1uL
EUR 532
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application

PC-3 Human prostate cancer cells derived from metastatic cancer cell line: >1x10^10 frozen exosomes
EXOP-115A-1 50 ug
EUR 409

Human Metastasis Associated In Colon Cancer 1 (MACC1) Antibody Pair Kit (with Standard)
MBS2104415-10x96Tests 10x96Tests
EUR 1615

Human Metastasis Associated In Colon Cancer 1 (MACC1) Antibody Pair Kit (with Standard)
MBS2104415-10x96TestsMBS2090685AbPairsSupportPack110x96Tests 10x96Tests+MBS2090685(AbPairsSupportPack1,10x96Tests)
EUR 1735

Human Metastasis Associated In Colon Cancer 1 (MACC1) Antibody Pair Kit (with Standard)
MBS2104415-5x96Tests 5x96Tests
EUR 1020

Human Metastasis Associated In Colon Cancer 1 (MACC1) Antibody Pair Kit (with Standard)
MBS2104415-5x96TestsMBS2090685AbPairsSupportPack15x96Tests 5x96Tests+MBS2090685(AbPairsSupportPack1,5x96Tests)
EUR 1090

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Mouse Monoclonal Antibody [Clone rFABP5/6354]
MBS4381879-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Mouse Monoclonal Antibody [Clone rFABP5/6354]
MBS4381879-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Mouse Monoclonal Antibody [Clone rFABP5/6354]
MBS4381879-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Mouse Monoclonal Antibody [Clone rFABP5/6354]
MBS4381879-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Mouse Monoclonal Antibody [Clone rFABP5/6354]
MBS4381879-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Rabbit Monoclonal Antibody [Clone FABP5/6353R]
MBS4381880-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Rabbit Monoclonal Antibody [Clone FABP5/6353R]
MBS4381880-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Rabbit Monoclonal Antibody [Clone FABP5/6353R]
MBS4381880-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Rabbit Monoclonal Antibody [Clone FABP5/6353R]
MBS4381880-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

FABP5 (Marker of Metastatic Potential in Colorectal Cancer) Recombinant Rabbit Monoclonal Antibody [Clone FABP5/6353R]
MBS4381880-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

Colon cancer with colon tissue array
CO1021a each
EUR 306
Description: Colon cancer with colon tissue array, including pathology grade, with MMR (MLH1/PMS2/MSH2/MSH6) IHC results,TNM and clinical stage, containing 86 cases of adenocarcinoma, 4 papillary adenocarcinoma, 7 mucinous adenocarcinoma, 2 adenoma, 1 congenital megacolon, 2 colon tissue, 102 cases/102 cores replacing CO1021

Colon cancer with colon tissue array
CO1921 each
EUR 546
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 192 cases/192 cores

Colon cancer with colon tissue array
CO2161b each
EUR 474
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 216 cases/216 cores, replacing CO2161a

Colon cancer with colon tissue array
CO721 each
EUR 270
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores

Colon cancer with colon tissue array
CO805 each
EUR 258
Description: Colon cancer with colon tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores

Metastasis-associated in colon cancer protein 1
AP84814 1mg
EUR 2640

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
20-abx242861
  • Ask for price
  • Ask for price
  • 50 ul
  • 150 ul

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx242861-96tests 96 tests
EUR 612.5

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx132298-100tests 100 tests
EUR 300

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
20-abx132298
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx375246-96tests 96 tests
EUR 337.5

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx210666-100l 100 µl
EUR 350

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
20-abx210666
  • Ask for price
  • Ask for price
  • 50 ul
  • 100 ul

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx210666-50l 50 µl
EUR 250

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx210667-100l 100 µl
EUR 350

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
20-abx210667
  • Ask for price
  • Ask for price
  • 50 ul
  • 100 ul

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx210667-50l 50 µl
EUR 250

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx338434-100g 100 µg
EUR 162.5

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
20-abx338434
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 20 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx234920-100g 100 µg
EUR 350

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx234920-100ug 100 ug
EUR 610.8

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
20-abx121640
  • Ask for price
  • Ask for price
  • Ask for price
  • 30 ul
  • 100 ul
  • 200 ul

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx104134-100g 100 µg
EUR 825

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
20-abx104134
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 50 ug
  • 100 ug
  • 200 ug
  • 1 mg

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx104134-20g 20 µg
EUR 287.5

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx104134-50g 50 µg
EUR 362.5

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx325504-100g 100 µg
EUR 250

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
20-abx325504
  • Ask for price
  • Ask for price
  • 50 ug
  • 100 ug

Metastasis Associated In Colon Cancer 1 (MACC1) Antibody
abx325504-50g 50 µg
EUR 187.5

Rat Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS097090-10x96StripWells 10x96-Strip-Wells
EUR 6725

Rat Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS097090-48StripWells 48-Strip-Wells
EUR 550

Rat Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS097090-5x96StripWells 5x96-Strip-Wells
EUR 3420

Rat Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS097090-96StripWells 96-Strip-Wells
EUR 765

Cat Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS068902-INQUIRE INQUIRE Ask for price

Fish Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS095307-INQUIRE INQUIRE Ask for price

Cavy Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS080232-INQUIRE INQUIRE Ask for price

Duck Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS054027-INQUIRE INQUIRE Ask for price

Goat Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS053444-INQUIRE INQUIRE Ask for price

MDA-MB-231 Human breast cancer, aggressive/invasive/metastatic cell line: >1x10^10 frozen exosomes
EXOP-105A-1 50 ug
EUR 409

Colon cancer with matched colon tissue array
CO1801a each
EUR 474
Description: Colon cancer with matched colon tissue array, including pathology grade,with MMR (MLH1/PMS2/MSH2/MSH6) IHC results, TNM and clinical stage, containing 90 cases of adenocarcinoma, and 90 cancer adjacent or adjacent normal colon tissue, 90 cases/180 cores, replacing CO1801

Colon cancer with matched colon tissue array
CO602a each
EUR 222
Description: Colon cancer with matched colon tissue array, including pathology grade, TNM and clinical stage, 30 cases/60 cores, replacing CO602

Colon cancer with matched colon tissue array
CO703 each
EUR 198
Description: Colon cancer with matched colon tissue array, including pathology grade, TNM and clinical stage, 35 cases/70 cores,replaced by CO703a

Human Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS108228-10x96StripWells 10x96-Strip-Wells
EUR 6725

Human Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS108228-48StripWells 48-Strip-Wells
EUR 550

Human Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS108228-5x96StripWells 5x96-Strip-Wells
EUR 3420

Human Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS108228-96StripWells 96-Strip-Wells
EUR 765

Human Metastasis Associated In Colon Cancer 1 ELISA Kit
IHUMACC1KT each
EUR 799
Description: Human Metastasis Associated In Colon Cancer 1 ELISA Kit

Camel Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS072580-10x96StripWells 10x96-Strip-Wells
EUR 6725

Camel Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS072580-48StripWells 48-Strip-Wells
EUR 550

Camel Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS072580-5x96StripWells 5x96-Strip-Wells
EUR 3420

Camel Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS072580-96StripWells 96-Strip-Wells
EUR 765

Sheep Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS060908-10x96StripWells 10x96-Strip-Wells
EUR 6725

Sheep Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS060908-48StripWells 48-Strip-Wells
EUR 550

Sheep Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS060908-5x96StripWells 5x96-Strip-Wells
EUR 3420

Sheep Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS060908-96StripWells 96-Strip-Wells
EUR 765

Horse Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS061108-10x96StripWells 10x96-Strip-Wells
EUR 6725

Horse Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS061108-48StripWells 48-Strip-Wells
EUR 550

Horse Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS061108-5x96StripWells 5x96-Strip-Wells
EUR 3420

Horse Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS061108-96StripWells 96-Strip-Wells
EUR 765

Mouse Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS088621-10x96StripWells 10x96-Strip-Wells
EUR 6725

Mouse Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS088621-48StripWells 48-Strip-Wells
EUR 550

Mouse Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS088621-5x96StripWells 5x96-Strip-Wells
EUR 3420

Mouse Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS088621-96StripWells 96-Strip-Wells
EUR 765

Goose Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS097938-INQUIRE INQUIRE Ask for price

Canine Metastasis Associated In Colon Cancer 1 ELISA Kit
MBS063715-10x96StripWells 10x96-Strip-Wells
EUR 6725

Colon primary cancer with metastatic